Correction: Aclacinomycin A sensitizes K562 chronic myeloid leukemia cells to imatinib through p38MAPK-mediated erythroid differentiation (PLoS ONE (2013) 8:4 (e61939) DOI: 10.1371/journal.pone.0061939)

Yueh Lun Lee; Chih Wei Chen; Fu Hwa Liu; Yu Wen Huang; Huei Mei Huang

doi:10.1371/journal.pone.0186528

Correction: Aclacinomycin A sensitizes K562 chronic myeloid leukemia cells to imatinib through p38MAPK-mediated erythroid differentiation (PLoS ONE (2013) 8:4 (e61939) DOI: 10.1371/journal.pone.0061939)

Yueh Lun Lee, Chih Wei Chen, Fu Hwa Liu, Yu Wen Huang, Huei Mei Huang

Research output: Contribution to journal › Comment/debate

Abstract

The affiliation for the first author is incorrect. Yueh-Lun Lee is affiliated with: Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

Original language	English
Article number	e0186528
Journal	PLoS One
Volume	12
Issue number	10
DOIs	https://doi.org/10.1371/journal.pone.0186528
Publication status	Published - Oct 1 2017

Fingerprint

ASJC Scopus subject areas

Biochemistry, Genetics and Molecular Biology(all)
Agricultural and Biological Sciences(all)

Cite this

Lee, Y. L., Chen, C. W., Liu, F. H., Huang, Y. W., & Huang, H. M. (2017). Correction: Aclacinomycin A sensitizes K562 chronic myeloid leukemia cells to imatinib through p38MAPK-mediated erythroid differentiation (PLoS ONE (2013) 8:4 (e61939) DOI: 10.1371/journal.pone.0061939). PLoS One, 12(10), [e0186528]. https://doi.org/10.1371/journal.pone.0186528

Correction : Aclacinomycin A sensitizes K562 chronic myeloid leukemia cells to imatinib through p38MAPK-mediated erythroid differentiation (PLoS ONE (2013) 8:4 (e61939) DOI: 10.1371/journal.pone.0061939). / Lee, Yueh Lun; Chen, Chih Wei; Liu, Fu Hwa; Huang, Yu Wen; Huang, Huei Mei.

In: PLoS One, Vol. 12, No. 10, e0186528, 01.10.2017.

Research output: Contribution to journal › Comment/debate

@article{ef6ee19bd3e048e4b23a99868038ced0,

title = "Correction: Aclacinomycin A sensitizes K562 chronic myeloid leukemia cells to imatinib through p38MAPK-mediated erythroid differentiation (PLoS ONE (2013) 8:4 (e61939) DOI: 10.1371/journal.pone.0061939)",

abstract = "The affiliation for the first author is incorrect. Yueh-Lun Lee is affiliated with: Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.",

author = "Lee, {Yueh Lun} and Chen, {Chih Wei} and Liu, {Fu Hwa} and Huang, {Yu Wen} and Huang, {Huei Mei}",

year = "2017",

month = oct,

day = "1",

doi = "10.1371/journal.pone.0186528",

language = "English",

volume = "12",

journal = "PLoS One",

issn = "1932-6203",

publisher = "Public Library of Science",

number = "10",

}

TY - JOUR

T1 - Correction

T2 - Aclacinomycin A sensitizes K562 chronic myeloid leukemia cells to imatinib through p38MAPK-mediated erythroid differentiation (PLoS ONE (2013) 8:4 (e61939) DOI: 10.1371/journal.pone.0061939)

AU - Lee, Yueh Lun

AU - Chen, Chih Wei

AU - Liu, Fu Hwa

AU - Huang, Yu Wen

AU - Huang, Huei Mei

PY - 2017/10/1

Y1 - 2017/10/1

N2 - The affiliation for the first author is incorrect. Yueh-Lun Lee is affiliated with: Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

AB - The affiliation for the first author is incorrect. Yueh-Lun Lee is affiliated with: Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

UR - http://www.scopus.com/inward/record.url?scp=85031023692&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031023692&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0186528

DO - 10.1371/journal.pone.0186528

M3 - Comment/debate

AN - SCOPUS:85031023692

VL - 12

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 10

M1 - e0186528

ER -

Access to Document

10.1371/journal.pone.0186528